Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01029Industry : ChemicalsHouse : Private

BSE529.2025.2 (+5 %)

PREV CLOSE ( ) 504.00

OPEN PRICE ( ) 514.80

BID PRICE (QTY) 529.20 (11139)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 111069

TODAY'S LOW / HIGH ( )513.00 529.20

52 WK LOW / HIGH ( ) 74.73504

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-02 1992

Management Info

Rohit Jain - Chairman Suresh Chand Singla - Managing Director

Registered Office

Address A - 902 A,R I I C O Industrial Area,Phase 3,
Bhiwadi,
Rajasthan-301019

Phone 011-27355742 / 27674615

Email hrd@titanbiotechltd.com / accounts@titanbiotechltd.com / purchase@titanbiotechltd.com

Website www.titanbiotechltd.com / www.tmmedia.in

Registrars Details

Beetal Financial & Computer Services (P) Ltd

Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi

Listing : BSE

NEWS

17Feb ISIN Change
Notice No. 20260217-11 Notice Date 17 Feb 2026Category Corporate..

03Jan Titan Biotech informs about outcome of
Titan Biotech has informed that the Board of Directors of the Company, a..

02Jan Titan Biotech informs about record date
Further to intimation dated November 29, 2025, regarding the approval of..

22Dec Titan Biotech informs about trading wi
Titan Biotech has informed that the trading window for dealing in the se..

29Nov Titan Biotec informs about outcome of
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	78.69	182.7
Gross Profit	105.63	243.66
Operating Profit	120.86	293.38
Net Sales	565.06	1564.51

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Polson (BSE) 10501.95 (4.96%)	M.Cap ( in Cr)125.94
Solar Industries (BSE) 13325.00 (1.68%)	M.Cap ( in Cr)120097.04
Styrenix Performance (BSE) 1887.95 (2.64%)	M.Cap ( in Cr)3338.37
Keltech Energies (BSE) 3241.65 (1.39%)	M.Cap ( in Cr)323.62
Yasho Industries (BSE) 1429.55 (2.39%)	M.Cap ( in Cr)1701.44

Shareholding Pattern

	PROMOTERS	55.78%
	NON-INSTITUTION	44.19%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

TITAN BIO-TECH LTD.